title: [Efficacy of Prostat in the treatment of NIH category IIIA prostatitis].
abstract: OBJECTIVE
  To evaluate the efficacy of Prostat in the treatment of NIH category IIIA prostatitis.
  
  
  METHODS
  An open clinical trial was conducted among 106 NIH category IIIA prostatitis patients. For each patient 1 tablet of Prostat (70 mg P5 + 4 mg EA10) was orally administered twice a day.
  
  
  RESULTS
  Subjective symptoms of the patients were significantly improved, particularly those of frequent micturition, urgent urination and peripheral region pains. Objective parameters also showed significant improvement. No adverse reaction associated with the medication was observed.
  
  
  CONCLUSIONS
  Prostat was shown to be an appropriate medicine in the treatment of NIH category IIIA prostatitis, with good curative effect and high safety.
authors.affiliation: Department of Urology, the People's Hospital of Sichuan Province, Chengdu, Sichuan 610072, China.
authors.forename: Hongtao
authors.initials: H
authors.lastname: Yan
authors.forename: Yong
authors.initials: Y
authors.lastname: Liao
authors.forename: Baisheng
authors.initials: B
authors.lastname: Gong
authors.forename: Zhaoxiang
authors.initials: Z
authors.lastname: Chen
mesh_terms: D000328:Adult; D006801:Humans; D008297:Male; D008875:Middle Aged; D008517:Phytotherapy; D011058:Pollen; D011472:Prostatitis / Q000188:drug therapy*; D016896:Treatment Outcome